Riot Platforms (NASDAQ: RIOT) has outperformed the market over the past 5 years by 25.34% on an annualized basis producing an average annual return of 39.95%. Currently, Riot Platforms has a market ...
Cloudflare (NYSE: NET) has outperformed the market over the past 5 years by 16.6% on an annualized basis producing an average annual return of 31.22%. Currently, Cloudflare has a market capitalization ...
Waste Management (NYSE: WM) has outperformed the market over the past 20 years by 1.35% on an annualized basis producing an average annual return of 10.35%. Currently, Waste Management has a market ...
Capital One Financial Corp (NASDAQ: COF) released its third-quarter earnings report after Tuesday's closing bell. Below is ...
ExlService Hldgs (NASDAQ: EXLS) has outperformed the market over the past 15 years by 4.97% on an annualized basis producing an average annual return of 17.23%. Currently, ExlService Hldgs has a ...
Compared to the aggregate P/E ratio of the 31.31 in the Consumer Staples Distribution & Retail industry, Weis Markets Inc.
nVent Electric (NYSE: NVT) has outperformed the market over the past 5 years by 24.51% on an annualized basis producing an average annual return of 39.12%. Currently, nVent Electric has a market ...
Keysight Techs (NYSE: KEYS) has outperformed the market over the past 10 years by 5.56% on an annualized basis producing an average annual return of 18.06%. Currently, Keysight Techs has a market ...
Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a low estimate of $85.00. Experiencing a 4.33% decline, the current average ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $38.14, a high estimate of $41.00, ...
Providing a diverse range of perspectives from bullish to bearish, 23 analysts have published ratings on Reddit (NYSE: RDDT) ...
United Therapeutics (NASDAQ: UTHR) has outperformed the market over the past 15 years by 2.22% on an annualized basis producing an average annual return of 14.48%. Currently, United Therapeutics has a ...